Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001839882-24-044127
Filing Date
2024-12-06
Accepted
2024-12-06 16:13:11
Documents
5
Effectiveness Date
2024-12-06

Document Format Files

Seq Description Document Type Size
1 INITIAL REGISTRATION STATEMENT tonix-s8_120624.htm S-8 59642
2 OPINION OF BROWNSTEIN HYATT FARBER SCHRECK, LLP* ex5-1.htm EX-5.1 10281
3 CONSENT OF EISNERAMPER LLP ex23-01.htm EX-23.01 3143
4 FILING FEE TABLE ex107.htm EX-FILING FEES 7945
5 GRAPHIC brownstein.jpg GRAPHIC 2822
  Complete submission text file 0001839882-24-044127.txt   86180
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-283651 | Film No.: 241532410
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)